Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer
双重 Rac/Cdc42 抑制剂 MBQ-167 对 HER2 过表达乳腺癌的疗效和给药策略
期刊:Translational Oncology
影响因子:4.5
doi:10.1016/j.tranon.2024.101928
Luis E Velázquez-Vega, Michael Rivera-Robles, Annelis O Sánchez-Álvarez, Pablo E Vivas-Mejía, Miciely Aponte-Reyes, Ailed M Cruz-Collazo, Nilmary Grafals-Ruiz, Stephanie Dorta-Estremera, Eliud Hernández-O'Farrill, Cornelis P Vlaar, Suranganie Dharmawardhane